HOWL Q1 2024 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOWLWerewolf Therapeutics, Inc.

$35M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$742,000-83.4% YoY

Gross Profit

$278,00037.5% margin

Operating Income

-$17M-2312.9% margin

Net Income

-$16M-2182.3% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

-50.6%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$178M

Total Liabilities

$60M

Stockholders' Equity

$118M

Cash & Equivalents

$139M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$742,000	$4M	-83.4%
Gross Profit	$278,000	$4M	-93.8%
Operating Income	-$17M	-$12M	-40.4%
Net Income	-$16M	-$12M	-35.1%